These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 2847840

  • 1. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
    Naafs MA, Hackeng WH, Koorevaar G, Silberbusch J.
    Bone Miner; 1988 Jul; 4(3):289-98. PubMed ID: 2847840
    [Abstract] [Full Text] [Related]

  • 2. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP, Patron P, Fouqueray B, Prigent A, Paillard M.
    Miner Electrolyte Metab; 1988 Jul; 14(4):221-8. PubMed ID: 2850460
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The usefulness of an oral calcium tolerance test in the choice of management of patients with idiopathic hypercalciuria.
    Naafs MA, Essed E, Hirdes WH, Hackeng WH, Fischer HR.
    Neth J Med; 1990 Jun; 36(5-6):223-7. PubMed ID: 2168524
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of age on the renal response to PTH infusion.
    Naafs MA, Fischer HR, Koorevaar G, Hackeng WH, Schopman W, Silberbusch J.
    Calcif Tissue Int; 1987 Nov; 41(5):262-6. PubMed ID: 2825933
    [Abstract] [Full Text] [Related]

  • 10. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD, Herman RH.
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [Abstract] [Full Text] [Related]

  • 11. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D, Wald H, Friedlaender MM, Silver J, Popovtzer MM.
    Miner Electrolyte Metab; 1988 Jan; 14(4):211-20. PubMed ID: 2850459
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S, Adchi I, Yamaguchi K, Suzuki M, Shimada A, Sato Y, Nagaoka K, Abe K.
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [Abstract] [Full Text] [Related]

  • 13. Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.
    Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3576-81. PubMed ID: 8530601
    [Abstract] [Full Text] [Related]

  • 14. Changes in nephrogenous cyclic AMP excretion and plasma cyclic AMP following treatment of hyperthyroidism.
    Naafs MA, van der Velden PC, Fischer HR, Koorevaar G, van Duin S, Hackeng WH, Schopman W, Silberbusch J.
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):477-81. PubMed ID: 6206676
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
    Bill G, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1983 Mar 05; 113(9):327-30. PubMed ID: 6302835
    [Abstract] [Full Text] [Related]

  • 16. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
    Law WM, Heath H.
    J Clin Invest; 1983 Sep 05; 72(3):1106-13. PubMed ID: 6309905
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD, Logue FC, Gallacher SJ, O'Reilly DS, Beastall GH, Ralston SH, Boyle IT.
    Bone Miner; 1991 Feb 05; 12(2):113-21. PubMed ID: 1849762
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.